Search research articles
Contact Us
Filters
Showing results (181-190 of 312) with videos related to
Page
of 32
Sort By:
The Lancet. Infectious Diseases
|
November 3, 2022
The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages
Prerna Arora, Lu Zhang, Inga Nehlmeier, et al.
The Journal of Infectious Diseases
|
October 12, 2011
Comparative analysis of Ebola virus glycoprotein interactions with human and bat cells
Annika Kühl, Markus Hoffmann, Marcel A Müller, et al.
The Lancet. Infectious Diseases
|
November 15, 2025
Epidemiological and virological update on the emerging SARS-CoV-2 variant BA.3.2
Lu Zhang, Nianzhen Chen, Amy Eichmann, et al.
Journal of Virology
|
January 12, 2022
Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases
M Zeeshan Chaudhry, Kathrin Eschke, Markus Hoffmann, et al.
Cellular & Molecular Immunology
|
May 8, 2023
Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage
Inga Nehlmeier, Amy Kempf, Prerna Arora, et al.
Chemical Science
|
October 27, 2021
Synergistic inhibition of SARS-CoV-2 cell entry by otamixaban and covalent protease inhibitors: pre-clinical assessment of pharmacological and molecular properties
Tim Hempel, Katarina Elez, Nadine Krüger, et al.
Journal of Virology
|
October 29, 2024
Acquisition of a multibasic cleavage site does not increase MERS-CoV entry into Calu-3 human lung cells
Markus Hoffmann, Hannah Kleine-Weber, Luise Graichen, et al.
Cellular & Molecular Immunology
|
March 3, 2023
Profound neutralization evasion and augmented host cell entry are hallmarks of the fast-spreading SARS-CoV-2 lineage XBB.1.5
Markus Hoffmann, Prerna Arora, Inga Nehlmeier, et al.
The Lancet. Infectious Diseases
|
September 16, 2023
Neutralisation sensitivity of SARS-CoV-2 lineages EG.5.1 and XBB.2.3
Lu Zhang, Amy Kempf, Inga Nehlmeier, et al.
Emerging Microbes & Infections
|
July 1, 2025
Neutralizing activity against bovine H5N1 HPAIV (clade 2.3.4.4b) in human plasma after seasonal influenza vaccination
Lu Zhang, Georg M N Behrens, Amy Kempf, et al.
Page
of 32
Search research articles
Search
Showing results (181-190 of 312) with videos related to
Sort By:
Page
of 32
The Lancet. Infectious Diseases
|
November 3, 2022
The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages
Prerna Arora, Lu Zhang, Inga Nehlmeier, et al.
The Journal of Infectious Diseases
|
October 12, 2011
Comparative analysis of Ebola virus glycoprotein interactions with human and bat cells
Annika Kühl, Markus Hoffmann, Marcel A Müller, et al.
The Lancet. Infectious Diseases
|
November 15, 2025
Epidemiological and virological update on the emerging SARS-CoV-2 variant BA.3.2
Lu Zhang, Nianzhen Chen, Amy Eichmann, et al.
Journal of Virology
|
January 12, 2022
Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases
M Zeeshan Chaudhry, Kathrin Eschke, Markus Hoffmann, et al.
Cellular & Molecular Immunology
|
May 8, 2023
Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage
Inga Nehlmeier, Amy Kempf, Prerna Arora, et al.
Chemical Science
|
October 27, 2021
Synergistic inhibition of SARS-CoV-2 cell entry by otamixaban and covalent protease inhibitors: pre-clinical assessment of pharmacological and molecular properties
Tim Hempel, Katarina Elez, Nadine Krüger, et al.
Journal of Virology
|
October 29, 2024
Acquisition of a multibasic cleavage site does not increase MERS-CoV entry into Calu-3 human lung cells
Markus Hoffmann, Hannah Kleine-Weber, Luise Graichen, et al.
Cellular & Molecular Immunology
|
March 3, 2023
Profound neutralization evasion and augmented host cell entry are hallmarks of the fast-spreading SARS-CoV-2 lineage XBB.1.5
Markus Hoffmann, Prerna Arora, Inga Nehlmeier, et al.
The Lancet. Infectious Diseases
|
September 16, 2023
Neutralisation sensitivity of SARS-CoV-2 lineages EG.5.1 and XBB.2.3
Lu Zhang, Amy Kempf, Inga Nehlmeier, et al.
Emerging Microbes & Infections
|
July 1, 2025
Neutralizing activity against bovine H5N1 HPAIV (clade 2.3.4.4b) in human plasma after seasonal influenza vaccination
Lu Zhang, Georg M N Behrens, Amy Kempf, et al.
Page
of 32